Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath® technique

Article ID	Journal	Published Year	Pages	File Type
8244504	International Journal of Radiation OncologyBiologyPhysics	2006	9 Pages	PDF

Abstract

Conclusion: Dose-escalated EBRT with the BeamCath® technique with doses up to 78 Gy is tolerable, and the toxicity profile is similar to that observed with conventional doses <71 Gy.

Keywords

Dose escalation Self-assessment Radiotherapy Prostate cancer Complications

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath® technique

Authors

Per Ph.D., Per M.D., Per-Olov Ph.D., Anders M.D., Ph.D.,